Toth Financial Advisory’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.76K Hold
25
– – ﹤0.01% 750
2026
Q2
$1.96K Hold
25
– – ﹤0.01% 753
2026
Q1
$1.62K Hold
25
– – ﹤0.01% 740
2025
Q4
$1.68K Hold
25
– – ﹤0.01% 730
2025
Q3
$1.83K Buy
+25
New +$1.66K ﹤0.01% 698
2024
Q4
– Sell
-1,000
Closed -$57.2K – 723
2024
Q3
$57.2K Buy
+1,000
New +$57.3K 0.01% 279

Other funds holding HALO

Toth Financial Advisory's HALO Position: Q3 2026 in Review

Toth Financial Advisory held its Halozyme (HALO) position steady in Q3 2026 at 25 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

Toth Financial Advisory first reported a position in HALO in Q3 2024 and has held it in 6 quarters since. The position peaked at $57.2K in Q3 2024. 249 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Toth Financial Advisory held 25 shares of Halozyme worth $2.76K as of Q3 2026.
  • Toth Financial Advisory left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #750 holding.
  • Toth Financial Advisory first reported a position in Halozyme in Q3 2024 and has held it in 6 quarters since.
  • Toth Financial Advisory's Halozyme position peaked at $57.2K in Q3 2024.
  • 249 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.